MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$47,594,000
EPS
-$0.42
Unit: Dollar

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Revenue
0 0 0 0
Restructuring
--68,000 -172,000 3,471,000
Research and development
31,454,000 29,347,000 34,068,000 42,658,000
General and administrative
17,057,000 14,684,000 18,351,000 25,020,000
Total operating expenses
48,511,000 43,963,000 52,247,000 71,149,000
Loss from operations
-48,511,000 -43,963,000 -52,247,000 -71,149,000
Interest expense
473,000 473,000 473,000 473,000
Interest and other income, net
161,000 690,000 709,000 483,000
Accretion of discount on investments, net
1,229,000 1,208,000 1,679,000 2,220,000
Net loss
-47,594,000 -42,538,000 -50,332,000 -68,919,000
Basic EPS
-0.42 -0.38 -0.45 -0.62
Diluted EPS
-0.42 -0.38 -0.45 -0.62
Basic Average Shares
112,134,059 111,810,836 111,571,136 111,019,647
Diluted Average Shares
112,134,059 111,810,836 111,571,136 111,019,647
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$47,594,000 (22.40%↑ Y/Y)Accretion of discount oninvestments, net$1,229,000 (-43.88%↓ Y/Y)Interest and otherincome, net$161,000 (-87.95%↓ Y/Y)Loss from operations-$48,511,000 (24.66%↑ Y/Y)Interest expense$473,000 (0.21%↑ Y/Y)Total operatingexpenses$48,511,000 (-24.66%↓ Y/Y)Research and development$31,454,000 (-12.49%↓ Y/Y)General andadministrative$17,057,000 (-40.04%↓ Y/Y)

ROCKET PHARMACEUTICALS, INC. (RCKT)

ROCKET PHARMACEUTICALS, INC. (RCKT)